
Judge denies NYPD union's bid to halt COVID vaccine mandate
The COVID-19 vaccine mandate is set to take effect on November 1.
Watch CBS News
The COVID-19 vaccine mandate is set to take effect on November 1.
An FDA advisory panel is endorsing a reduced-dose version of Pfizer's COVID-19 vaccine for kids aged 5 to 11. If the FDA and CDC sign off, shots for kids could be available by late next week. CBS News' Debra Alfarone reports, and then Dr. Stanley Perlman, a member of the FDA panel, joins CBSN's Tanya Rivero to discuss to vaccine and what it means for children and parents.
A Food and Drug Administration advisory committee is meeting Tuesday to consider endorsing Pfizer's COVID-19 vaccine for children ages 5 to 11. Dr. Mark Kline, chief physician at New Orleans Children's Hospital, spoke with CBSN's Tanya Rivero about what's next.
FDA advisers are meeting to consider recommending the Pfizer COVID-19 vaccine for kids aged 5 to 11. Meanwhile, Moderna says its data shows a strong immune response in young children from its shot. Dr. Dyan Hes, founder of Gramercy Pediatrics, joined CBSN to discuss these latest developments.
Former acting CDC Director Dr. Richard Besser, pediatrician and president of the Robert Wood Johnson Foundation, weighs in on vaccines for children age 5 to 11.
Gottlieb said the Biden administration is making the effort to push the vaccine directly into pediatricians' offices.
The Food and Drug Administration says the "overall benefits" of the Pfizer vaccine designed for children between the ages of 5 and 11 "may outweigh the risks." Meanwhile, nearly 100 million more Americans are now eligible for booster shots. CBS News' Elise Preston reports. Then, Dr. Robert Frenck, director of vaccine research at Cincinnati Children's Hospital, joins CBSN to discuss the new developments.
Millions more Americans can get COVID-19 booster shots after the Centers for Disease Control and Food and Drug Administration approved extra doses of the Moderna and Johnson and Johnson vaccines. Epidemiologist Dr. Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota, joins CBSN to discuss mixing and matching vaccines and getting children inoculated.
A CDC panel has voted in favor of the Johnson and Johnson and Moderna COVID-19 vaccine booster shots. Pending approval from the agency's director, millions of people could soon line up for an additional dose. CBS News' Meg Oliver breaks down the decision. Then, critical care physician Dr. Lakshmana Swamy joins CBSN's Lana Zak with his analysis.
Nicholas Burns, President Biden's nominee for U.S. ambassador to China, called the country the "most dangerous competitor" to the U.S. And India celebrated administering 1 billion COVID-19 vaccine doses Thursday, even as a recent drop in inoculations worries health care providers. Haley Ott reports from London on these and other stories from around the world.
The CDC must also weigh in before additional doses can be administered nationwide.
President Biden visited Scranton, Pennsylvania, on Wednesday to promote key aspects of his economic agenda to working class Americans. Back in Washington, Democrats are inching closer to an agreement on a spending bill for investments in social and climate infrastructure. CBS News senior White House correspondent Weijia Jiang joins CBSN's Lana Zak with the latest on negotiations, as well as voting rights reform and pediatric COVID-19 vaccines.
The FDA has authorized COVID-19 booster shots for some recipients of the Johnson and Johnson and Moderna vaccines. But as Nikki Battiste reports, the agency says eligible Americans can get any brand of booster, regardless of the shot they initially got. Then, Dr. Elizabeth Clayborne, an emergency physician and adjunct professor of emergency medicine at the University of Maryland School of Medicine, joins CBSN's Lana Zak with her analysis.
Democratic presidential candidate Joe Biden is calling on all governors to implement a mask mandate for every American and his running mate Kamala Harris is criticizing the Trump administration on the coronavirus vaccine. Ed O'Keefe reports.
President Vladimir Putin declared that Russia has approved a vaccine for the coronavirus, but it comes after less than two months of testing. Charlie D'Agata has the latest.
President Trump traveled to North Carolina on Monday for a tour of plant making a potential coronavirus vaccine. With less than 100 days to go until the election, CBS News political analyst Leslie Sanchez and CBSN political contributor Lynda Tran joined CBSN's "Countdown to the Vote" special with more.
While vaccines are readily available, uptake has remained stubbornly low amid widespread mistrust. Now the Kremlin is ordering all businesses to close in a bid to gain control.
Large outdoor crowds might not be as dangerous for COVID-19 infection as once feared, if safety precautions are taken. But as colder months approach, people will be heading inside, sparking fears of more cases. Dr. Christine Petersen, the director of the Center for Emerging Infectious Diseases at the University of Iowa College of Public Health, joined CBSN to discuss coronavirus precautions.
The mandate affecting the nation's largest police department and over100,000 other workers carries a Nov. 1 deadline for getting the first vaccine dose.
Children will soon be able to get a COVID-19 vaccine at their pediatrician's office, local pharmacy and potentially even their school.
Firefighters and police officers in cities like Chicago, Seattle and Los Angeles are facing the ultimatum: get vaccinated or lose your job.
The CDC released a study showing that coronavirus vaccines are highly effective at preventing hospitalizations, especially among kids, just as the pace of vaccinations is slowing. Lilia Luciano has the details on the findings. Then, Dr. Adam Brown, an emergency physician and the COVID-19 task force chair at Envision Healthcare, joins CBSN's Elaine Quijano to discuss the latest.
The five people who died in an attack in Norway last week were actually killed by a "sharp object" and not a bow and arrow as was initially reported, authorities say, though arrows were shot during the attack. Ian Lee reports from London on this and other stories from around the world.
The Food and Drug Administration is reportedly close to approving "mixing and matching" COVID booster shots. CBS News' Skyler Henry reports that people could soon get a different shot than the one they originally received and Dr. Theodore Strange, chair of medicine at Staten Island University Hospital in New York City, joined CBSN to discuss what this means, especially for immunocompromised Americans.
The Food and Drug Administration is considering giving the green light to mixing and matching COVID-19 vaccine booster shots. Meanwhile, the death of former Secretary of State Colin Powell is focusing attention on so-called breakthrough COVID-19 cases among people with compromised immune systems. Dr. Jeremy Faust, an emergency physician at Brigham and Women's Hospital in Boston, joined CBSN to discuss.
Conservative activist and Turning Point USA co-founder Charlie Kirk died Wednesday after he was shot at an event at Utah Valley University.
Charlie Kirk died Wednesday after he was shot in the neck while speaking at an event at Utah Valley University.
A new lawsuit filed by fired FBI agents says the bureau "tried to put the President in jail and he hasn't forgotten it."
Former Vice President Kamala Harris' book, "107 Days," will detail her sprint of a race for the presidency.
Authorities said a boy opened fire with a handgun Wednesday at a high school near Denver, Colorado, wounding two students. One of the three later died, but authorities did not immediately confirm if the deceased was the suspect or one of the two victims.
It's unclear if the repeal will end up in the final version of the National Defense Authorization Act, which still has to get through the Senate.
NASA's Mars rover Perseverance has uncovered rocks in a dry river channel that may hold potential signs of ancient microscopic life.
Oracle co-founder Larry Ellison took the title of world's richest person from Elon Musk after stock in the software giant shot up on Wednesday.
Passengers endured 2.5 minutes of turbulence that caught the pilots by surprise even though they had already altered their route to avoid the storms, the NTSB said.